Here we report on a large cohort of participants with confirmed
RS1 mutations and examine the symmetry between eyes in the outcome measures of acuity, OCT, and ERG. Previous publications have pointed to the spectrum of disease phenotype observed across individuals with XLRS. In those studies, a variety of factors were thought to contribute to the spectrum of clinical manifestations observed, including underlying genetic mutation
17 and age, among others.
17–19,24,25 By limiting our analysis to the comparison of the two eyes of a given participant, we inherently keep these known and unknown variables constant and find that the characteristics of one eye mirror the structural and functional findings in the fellow eye in highly predictable fashion.
Some have noted that the classic clinical finding of central cystic changes that seem almost pathognomonic for diagnosing the disease are not necessarily seen in the older population.
19 CMT ranged from 117 to 868 μm in this study, and the knowledge of the thickness in one eye highly predicted the CMT findings in the fellow eye, with a value of
r = 0.83. In a similar manner, the electronegative b-wave that is often discussed as the electrophysiologic signature of this disease is quantitatively variable, with all patients demonstrating a reduced b/a ratio, but not all reaching the definition of electronegative. Although there is a large spectrum of the degree to which the b-wave is reduced relative to the a-wave across patients (b/a ratio range, 0.23–1.7), we demonstrate here that the two eyes of a patient with XLRS are highly correlated (
r value = 0.80) with highly similar reductions in their b-wave relative to a-waves.
The clinical phenotype of XLRS patients has been described since 1898
26 and yet few have reported on the long-term follow-up of this cohort. To our knowledge, this is the largest published cohort of patients with molecularly proven XLRS with long-term follow-up. Consistent with other investigators who have evaluated visual acuity longitudinally in patients with XLRS, we find relatively stable measures at different time points (
Fig. 7) unless severe complications occurred.
27 Frequency of complications, such as vitreous hemorrhage and retinal detachment have been reported by George et al.,
28 Kellner et al.,
29 Roesch et al.,
30 and most recently Fahim et al.
31 In our cohort, we identified retinal detachment in 10.8% of patients and vitreous hemorrhage in 11.7%; only three patients had a history of both retinal detachment and vitreous hemorrhage. This is comparable, although on the lower end of the range of 3% to 21% vitreous hemorrhage and 5% to 40% retinal detachment reported in the literature.
28–32 Of the participants who had a more than 15-letter difference between eyes, several had strabismus or structural macular changes that could contribute to this decreased visual acuity. Any structural or functional disparity between eyes has the potential to lead to amblyopia, and the contribution of developmental visual loss is impossible to separate completely from any biologic disparity. The presence of strabismus suggests a component of amblyopia that could be contributing to the asymmetry in visual acuity between eyes. The impact of age and accuracy of initial visual acuity also must be considered in the group of patients who demonstrated a loss of 15 letters or more over time. We also find stable ERG parameters when patients are followed longitudinally. Although there was an increase in 30-Hz latency in patients with three visits and at least 3 years of follow-up, this statistical change was not maintained when analyzed in patients with at least 5 years of follow-up (
Table 4).
Currently there are no treatments approved by the Food and Drug Administration for patients with XLRS, but with successful preclinical studies in mouse models
33,34 and multiple Phase I/II clinical trials involving AAV-mediated gene therapy under way, it is imperative to understand the natural progression of disease when choosing outcome measures for an interventional study. Our findings indicate that, given the same mutation in the same biologic milieu of an individual, the structure and function of the retina in the two eyes is similar. That is, barring accidental injury to one eye, including the infrequent occurrence of a retinal detachment, or the presence of strabismus, one can conclude visual acuity, CMT on OCT, and electrophysiologic measures are quite comparable between eyes and will likely remain that way over time. These results highlight the potential for monocular treatments to use the fellow eye as an appropriate comparison reference. The finding of a strong correlation of structural and functional measures between the two eyes of a given participant as well as the stability of these measures over time will undoubtedly prove useful for analyses involving a uniocular intervention.